Search Results

Bioymifi 25 mg  | Purity Not Available

TargetMol

Bioymifi is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells.

More Information Supplier Page

Clemizole hydrochloride 5 mg  | 99.91%

TargetMol

Clemizole hydrochloride is an antagonist for H1 histamine receptor. According to the research, Clemizole hydrochloride can inhibit hepatitis C virus (HCV) replication and NS4B’s RNA binding.

More Information Supplier Page

Clemizole hydrochloride 50 mg  | 99.91%

TargetMol

Clemizole hydrochloride is an antagonist for H1 histamine receptor. According to the research, Clemizole hydrochloride can inhibit hepatitis C virus (HCV) replication and NS4B’s RNA binding.

More Information Supplier Page

GSK 3 Inhibitor IX 10 mg  | 99.90%

TargetMol

GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively.

More Information Supplier Page